Continuous low dose rate brachytherapy with high activity iodine-125 seeds in the management of meningiomas

Pradeep P. Kumar, Arun-Angelo Patil, Lyal G. Leibrock, Wei Kom Chu, Hon wei Syh, Gayle F. Mccaul, Michael A. Reeves

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

The purpose of this study was to evaluate if meningiomas can be effectively treated with brachytherapy using permanent implantation of high activity 1-125 seeds. Thirteen patients with intracranial meningiomas were treated by means of permanent stereotactic implantation of one or more high-activity 1-125 seeds. The physical characteristics of I-25 enabled us to deliver a minimum tumor dose ranging from 100 Gy to 500 Gy at a low dose rate of 5 cGy to 25 cGy per hr. Indications for this procedure included recurrence after initial surgery or as primary modality of treatment in patients who were not candidates for surgery. All 13 patients are alive at a median follow-up of 25 months. Nine of 13 patients achieved complete resolution of the tumor and in the remaining four, more than 50 reduction in tumor volume was noted at the last follow-up. No late complications were observed. We conclude from this initial data that localized high dose irradiation delivered at a low dose rate using 1-125 permanent implantation is an effective, safe, and simple method in the treatment of both recurrent and primary intracranial meningiomas.

Original languageEnglish (US)
Pages (from-to)325-328
Number of pages4
JournalInternational Journal of Radiation Oncology, Biology, Physics
Volume25
Issue number2
DOIs
StatePublished - Jan 15 1993

Fingerprint

iodine 125
Brachytherapy
Meningioma
Iodine
seeds
Seeds
implantation
dosage
tumors
surgery
Tumor Burden
Neoplasms
indication
Recurrence
irradiation
Therapeutics

Keywords

  • 1-125 stereotactic brachytherapy
  • Low dose rate irradiation
  • Meningioma

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Radiation

Cite this

Continuous low dose rate brachytherapy with high activity iodine-125 seeds in the management of meningiomas. / Kumar, Pradeep P.; Patil, Arun-Angelo; Leibrock, Lyal G.; Chu, Wei Kom; Syh, Hon wei; Mccaul, Gayle F.; Reeves, Michael A.

In: International Journal of Radiation Oncology, Biology, Physics, Vol. 25, No. 2, 15.01.1993, p. 325-328.

Research output: Contribution to journalArticle

Kumar, Pradeep P. ; Patil, Arun-Angelo ; Leibrock, Lyal G. ; Chu, Wei Kom ; Syh, Hon wei ; Mccaul, Gayle F. ; Reeves, Michael A. / Continuous low dose rate brachytherapy with high activity iodine-125 seeds in the management of meningiomas. In: International Journal of Radiation Oncology, Biology, Physics. 1993 ; Vol. 25, No. 2. pp. 325-328.
@article{627aec1aa6b5490c9c72be12bb6884f4,
title = "Continuous low dose rate brachytherapy with high activity iodine-125 seeds in the management of meningiomas",
abstract = "The purpose of this study was to evaluate if meningiomas can be effectively treated with brachytherapy using permanent implantation of high activity 1-125 seeds. Thirteen patients with intracranial meningiomas were treated by means of permanent stereotactic implantation of one or more high-activity 1-125 seeds. The physical characteristics of I-25 enabled us to deliver a minimum tumor dose ranging from 100 Gy to 500 Gy at a low dose rate of 5 cGy to 25 cGy per hr. Indications for this procedure included recurrence after initial surgery or as primary modality of treatment in patients who were not candidates for surgery. All 13 patients are alive at a median follow-up of 25 months. Nine of 13 patients achieved complete resolution of the tumor and in the remaining four, more than 50 reduction in tumor volume was noted at the last follow-up. No late complications were observed. We conclude from this initial data that localized high dose irradiation delivered at a low dose rate using 1-125 permanent implantation is an effective, safe, and simple method in the treatment of both recurrent and primary intracranial meningiomas.",
keywords = "1-125 stereotactic brachytherapy, Low dose rate irradiation, Meningioma",
author = "Kumar, {Pradeep P.} and Arun-Angelo Patil and Leibrock, {Lyal G.} and Chu, {Wei Kom} and Syh, {Hon wei} and Mccaul, {Gayle F.} and Reeves, {Michael A.}",
year = "1993",
month = "1",
day = "15",
doi = "10.1016/0360-3016(93)90355-Y",
language = "English (US)",
volume = "25",
pages = "325--328",
journal = "International Journal of Radiation Oncology Biology Physics",
issn = "0360-3016",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Continuous low dose rate brachytherapy with high activity iodine-125 seeds in the management of meningiomas

AU - Kumar, Pradeep P.

AU - Patil, Arun-Angelo

AU - Leibrock, Lyal G.

AU - Chu, Wei Kom

AU - Syh, Hon wei

AU - Mccaul, Gayle F.

AU - Reeves, Michael A.

PY - 1993/1/15

Y1 - 1993/1/15

N2 - The purpose of this study was to evaluate if meningiomas can be effectively treated with brachytherapy using permanent implantation of high activity 1-125 seeds. Thirteen patients with intracranial meningiomas were treated by means of permanent stereotactic implantation of one or more high-activity 1-125 seeds. The physical characteristics of I-25 enabled us to deliver a minimum tumor dose ranging from 100 Gy to 500 Gy at a low dose rate of 5 cGy to 25 cGy per hr. Indications for this procedure included recurrence after initial surgery or as primary modality of treatment in patients who were not candidates for surgery. All 13 patients are alive at a median follow-up of 25 months. Nine of 13 patients achieved complete resolution of the tumor and in the remaining four, more than 50 reduction in tumor volume was noted at the last follow-up. No late complications were observed. We conclude from this initial data that localized high dose irradiation delivered at a low dose rate using 1-125 permanent implantation is an effective, safe, and simple method in the treatment of both recurrent and primary intracranial meningiomas.

AB - The purpose of this study was to evaluate if meningiomas can be effectively treated with brachytherapy using permanent implantation of high activity 1-125 seeds. Thirteen patients with intracranial meningiomas were treated by means of permanent stereotactic implantation of one or more high-activity 1-125 seeds. The physical characteristics of I-25 enabled us to deliver a minimum tumor dose ranging from 100 Gy to 500 Gy at a low dose rate of 5 cGy to 25 cGy per hr. Indications for this procedure included recurrence after initial surgery or as primary modality of treatment in patients who were not candidates for surgery. All 13 patients are alive at a median follow-up of 25 months. Nine of 13 patients achieved complete resolution of the tumor and in the remaining four, more than 50 reduction in tumor volume was noted at the last follow-up. No late complications were observed. We conclude from this initial data that localized high dose irradiation delivered at a low dose rate using 1-125 permanent implantation is an effective, safe, and simple method in the treatment of both recurrent and primary intracranial meningiomas.

KW - 1-125 stereotactic brachytherapy

KW - Low dose rate irradiation

KW - Meningioma

UR - http://www.scopus.com/inward/record.url?scp=0027409933&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027409933&partnerID=8YFLogxK

U2 - 10.1016/0360-3016(93)90355-Y

DO - 10.1016/0360-3016(93)90355-Y

M3 - Article

VL - 25

SP - 325

EP - 328

JO - International Journal of Radiation Oncology Biology Physics

JF - International Journal of Radiation Oncology Biology Physics

SN - 0360-3016

IS - 2

ER -